The Institute of Medicine has proposed the FDA create a central management plan for every new drug to strengthen oversight of drugs over the entire life cycle.
Read the full report in Becker’s Hospital Review on the IOM report.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.